DAPOFORCE 30

What is DAPOFORCE 30?

The drug DAPOFORCE 30 is a modern specialized medicine developed for the effective correction of functional disorders of the male sexual sphere. This medication belongs to the pharmacotherapeutic group of selective serotonin reuptake inhibitors with a short duration of action. The main purpose of this pharmaceutical product is to restore control over the ejaculation process and significantly prolong the duration of sexual intercourse. The production of this product is carried out by the well-known pharmaceutical company Healing Pharma, which has established itself as a reliable manufacturer of highly effective and safe medical drugs that comply with strict international GMP quality standards.

The release form of DAPOFORCE 30 is oral tablets coated with a protective film sheath, which ensures gradual and proper absorption of the active component in the gastrointestinal tract. Each tablet contains a clearly dosed amount of the active substance, which allows achieving a predictable and stable therapeutic effect without the risk of accidental overdose. The drug belongs to the category of specialized prolongators created for men who seek to improve the quality of their intimate life and overcome psychological discomfort associated with physiological failures. Healing Pharma's pharmaceutical development combines high bioavailability and a minimal half-life, making it the optimal choice for episodic use without the need for a long daily course.

The main active element of this product is dapoxetine in a dosage of 30 mg, which is considered the standard starting dose for most male patients. The medication acts purposefully on the neurochemical mechanisms of the central nervous system, regulating the level of important neurotransmitters in the brain. It allows men to get rid of feelings of anxiety and insecurity that often accompany sexual disorders and worsen the psycho-emotional state. It is important to emphasize that the product is not a stimulant of artificial origin and does not directly affect the hormonal background, preserving the natural physiological reactions of the body to sexual stimulation. A complete description of pharmacological properties makes DAPOFORCE 30 an important tool in modern andrology and sexopathology.

What is DAPOFORCE 30 prescribed for?

The main indication for the use of the medicinal product DAPOFORCE 30 is premature ejaculation in adult men aged 18 to 64 years. This disorder is characterized by persistent or recurrent onset of ejaculation with minimal sexual stimulation occurring before, during, or immediately after penetration. The use of the medication allows delaying the ejaculation reaction, significantly increasing the latency time of intravaginal ejaculation. This contributes to a significant improvement in the quality of sexual contact for both partners, relieves tension, and restores harmony in personal relationships.

In addition to the direct physiological effect, the drug is prescribed to reduce pronounced psychological discomfort and interpersonal difficulties caused by a rapid finish. Men who face this problem often experience fear of failure, suffer from reduced self-esteem, and may develop avoidant behavior regarding intimate contacts. Thanks to its ability to improve control over ejaculation, this product helps overcome emotional stress and anxiety. Normalization of sexual function has a positive effect on the general psycho-emotional state of the patient, returning confidence in one's own strength and the ability to obtain full satisfaction.

It should be noted that therapy with the use of DAPOFORCE 30 is exclusively symptomatic and is prescribed by a doctor after a thorough diagnosis. The drug is suitable both for men who have a primary (permanent) form of the disorder and for those whose problem is of an acquired nature against the background of stress or other factors. The use of this pharmaceutical agent allows a man to independently regulate the duration of sexual intercourse, which makes the intimate process more predictable and harmonious. Before starting use, it is important to undergo a professional examination to exclude other concomitant pathologies of the genitourinary system.

Composition and active components of DAPOFORCE 30

The main active substance of the drug is dapoxetine 30 mg in the form of hydrochloride, which acts as a key functional element of the medication. The pharmacological mechanism of action of this substance is based on the inhibition of serotonin reuptake by neurons of the central nervous system, followed by enhancement of the action of this neurotransmitter on pre- and postsynaptic receptors. Serotonin plays a leading role in the regulation of ejaculation processes through the sympathetic nervous system, being responsible for delaying the transmission of nerve impulses to the genital organs. Rapid absorption of dapoxetine allows achieving maximum concentration in blood plasma as early as one hour after administration, which ensures a prompt therapeutic effect.

In addition to the active component, the composition of the tablet includes carefully selected excipients that ensure the stability of the formula, the required rate of dissolution, and optimal absorption. These include microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, magnesium stearate, and colloidal silicon dioxide. The film coating contains hypromellose, titanium dioxide, and special colorants that protect the active substance from the negative effects of the external environment, moisture, and gastric juice. All components meet strict pharmaceutical purity requirements and are well tolerated by the body of most patients.

Dosage of DAPOFORCE 30

The recommended starting dose for all adult male patients is one tablet of DAPOFORCE 30 1–3 hours before the intended sexual intercourse. This dosage is optimal for the initial intake, as it allows assessing the individual efficacy and tolerability of the drug by the body. It is not recommended to use the product more than once every 24 hours, as this does not increase the therapeutic effect but significantly increases the risk of developing undesirable side reactions. If necessary and provided there is good tolerability, the doctor may decide to adjust the dose in the future.

The duration of treatment courses is determined by the doctor individually based on the clinical picture and analysis of the therapy's effectiveness. The drug is not intended for daily regular use; it should be used only as needed (on demand) before planned sexual activity. After the first 4 weeks of use or after taking at least 6 doses, the doctor must conduct a re-assessment of the benefit-risk ratio to make a decision on the feasibility of continuing treatment. Dose adjustment for elderly patients without concomitant severe diseases is usually not required, but increased caution is necessary.

How to take DAPOFORCE 30 correctly?

The DAPOFORCE 30 tablet should be swallowed whole, without chewing or crushing, to prevent an unpleasant bitter taste and ensure proper release of the substance. The drug must be washed down with a large glass of water (at least 200 ml), which contributes to faster dissolution and reduces the risk of unpleasant sensations in the gastrointestinal tract. The product can be taken regardless of food intake, but it should be borne in mind that eating excessively fatty food can somewhat slow down the absorption of the active component into the blood. To achieve maximum effect, it is important to observe the time interval, taking the medication 1–3 hours before intimate closeness.

If for some reason the intake of the drug was missed, and sexual contact has already occurred, you should not take a double dose to compensate. Simply take it next time according to the instructions as needed, keeping in mind the strict limitation of no more than one tablet per day. During the use of this pharmaceutical product, dehydration of the body should be avoided, so it is important to maintain an adequate water balance throughout the day. Patients are advised to refrain from sudden changes in body position (for example, standing up quickly from a sitting or lying position) to prevent possible orthostatic hypotension.

Side effects of DAPOFORCE 30

The use of the medicinal product DAPOFORCE 30 can cause certain side effects, which are usually mild or moderate in nature and quickly pass on their own. The most common adverse reactions include nausea, dizziness, headache, increased sweating, and insomnia or increased somnolence. Patients may also experience digestive disorders such as diarrhea, dry mouth, stomach discomfort, or abdominal bloating. In most cases, these symptoms manifest at the beginning of therapy and gradually disappear as the body adapts to the active substance.

Uncommon and rare side effects include orthostatic hypotension, syncope, blurred vision, tinnitus, rapid heartbeat (tachycardia), and increased blood pressure. In rare cases, the development of anxiety, agitation, mood changes, or allergic skin reactions (rash, itching) is possible. If during the intake of the drug you feel a sudden worsening of well-being, dizziness with loss of orientation, or signs of a serious allergic reaction, you must immediately stop using the product and seek qualified medical help.

Contraindications of DAPOFORCE 30

The drug DAPOFORCE 30 has a number of absolute contraindications, in the presence of which its use is categorically prohibited due to a high risk to health. The medication is not prescribed to patients with hypersensitivity to dapoxetine or any other excipient of the tablet. Use is contraindicated in severe heart diseases, such as heart failure (NYHA II-IV), conduction disorders (AV block of II-III degree), sick sinus syndrome, pronounced ischemic heart disease, or the presence of an artificial pacemaker. Also, moderate and severe hepatic or renal impairment is an absolute contraindication.

The product is categorically prohibited for use in women, as well as children and adolescents under 18 years of age. The drug is not intended for use by elderly persons (over 65 years) without a special prescription and close monitoring by a doctor. With particular caution and after a strict risk assessment, the product is prescribed to patients with a history of seizures, unstable epilepsy, open-angle glaucoma, or increased intraocular pressure, as well as people with blood clotting disorders. In the case of depressive disorders or manic states, the use of this prolongator is undesirable.

Interaction of DAPOFORCE 30 with other drugs and alcohol

Concomitant use of DAPOFORCE 30 with many groups of medicinal products requires special caution or is completely contraindicated due to the threat of developing severe complications. It is forbidden to combine the agent with monoamine oxidase inhibitors (MAOIs), thioridazine, selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, and other serotonergic drugs. At least 14 days must pass between taking these agents and dapoxetine. Also dangerous is the interaction with potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, ritonavir, and some antibiotics, which can significantly increase the concentration of the active substance in the blood.

It is categorically not recommended to consume alcoholic beverages during the use of this pharmaceutical product. Alcohol enhances the neurotoxic effect of dapoxetine on the central nervous system, significantly increasing the risk of dizziness, drowsiness, slowed reactions, and syncope. In addition, the combination with alcohol significantly reduces the therapeutic efficacy of the medication and can lead to undesirable spikes in blood pressure. Patients who drive motor vehicles or work with potentially dangerous machinery should take into account the possibility of dizziness and decreased concentration of attention.

Where to buy DAPOFORCE 30 in Ukraine

You can purchase DAPOFORCE 30 in Ukraine in licensed pharmacy chains, as well as in specialized online pharmacies engaged in the sale of certified pharmaceutical products. When purchasing through online platforms, complete anonymity and prompt delivery to any corner of the country are ensured using popular postal operators. The drug must be stored in its original packaging in a dry place protected from direct sunlight and out of reach of children at a temperature not exceeding 25 °C. Do not use the medication after the expiration date indicated on the blister and cardboard box.

Please note that the information about DAPOFORCE 30 is provided solely for informational purposes and should not be used as a guide for self-treatment. Before starting to take this product, consultation with a doctor (urologist or andrologist) is mandatory to establish an accurate diagnosis and exclude contraindications. Remember the individual reaction of the body to the active components, which may differ depending on the general state of health and the presence of concomitant diseases. Self-treatment can be harmful to your health.